RESOURCES

Per- and polyfluoroalkyl substances (PFAS) are a class of thousands of "forever chemicals" that have been used in a wide variety of products since the 1950s. Generally, they are found in nonstick coatings on packaging and cookware, stain-resistant clothes and carpets, paints and coatings, firefighting foam, wire jackets, cosmetics and hygiene products, and many other products used daily.

If you manufacture and sell children's furniture or furnishings on Amazon, compliance is not optional. Amazon requires children's products intended for use by children up to 12 years of age to comply with applicable federal, state, and local regulations. But beyond meeting baseline legal requirements, today's parents and retail buyers want proof that the products their children use every day are genuinely safe.

Materials Analytical Services, LLC (MAS) and the MAS Certified Green ® Low VOC Materials Certification Program are excited to announce a professional services agreement with Sustainable Stewardship Private Limited of New Delhi, India. Under the agreement, Sustainable Partnership P.L. agrees to refer all of its clients seeking VOC emissions testing and certification to MAS for testing and to the MAS Certified Green ® Program for certification.

A recent Fox 4 News report highlighted a recall of countertop ovens due to a burn hazard, after consumers reported incidents involving hot contents and unexpected breakage or failure of components. Although the specific product and brand may change from recall to recall, the underlying message is consistent: product safety issues tied to materials, coatings or construction can quickly become public, expensive and damaging to a brand.

Sustainability has moved from a niche talking point to a central expectation in the furniture industry. Designers, manufacturers, retailers, and buyers are all rethinking what “good furniture” means – not just in terms of style and comfort, but in terms of materials, emissions, durability, and end‑of‑life impact. 

A March 2025 ruling by a federal judge in Texas has thrown the FDA’s new laboratory-developed test (LDT) rule into uncertainty, with major implications for clinical laboratories and test developers.